Exscientia Plc (EXAI) Return on Equity ROE from the third quarter 2024 to third quarter 2023 and annually, average high and low, overall ranking from Sep 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Exscientia Plc  (NASDAQ: EXAI)

Exscientia Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Exscientia Plc in the third quarter 2024?
Exscientia Plc recorded a cumulative net loss of $-204 million during 12 months ending in the third quarter 2024, resulting in a negative return on equity (ROE) of -49.5%.

Within the Biotechnology & Pharmaceuticals industry 50 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2024 from 0 to 3807.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Equity Change -35.47 % -32.43 % -21.62 % -15.64 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -204 -181 -181 -179 -181
Return On Equity (TTM) -49.5 % -39.48 % -35.97 % -33.35 % -32.42 %
EXAI's Total Ranking # 3807 # 0 # # #
Equity (TTM) in Millions 342 374 453 480 530
Seq. Equity Change -8.54 % -17.45 % -5.56 % -9.49 % -4.24 %
Seq. Net Income Change - - - - -

Back to EXAI Management Effectiveness >> EXAI's 5 Years Annual ROE >> Compare EXAI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 51
Sector # 422
Overall # 3807

Return On Equity Statistics
High Average Low
-25.4 %
-32.73 %
-40.06 %
(Dec 31 2022)   (Dec 31 2023)





EXAI Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Equity in Millions 453 578 765 0 0
Y / Y Equity Change -21.62 % -24.42 % - - -
Net Income in Millions -182 -147 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -40.06 % -25.4 % 0 % - -

Back to EXAI Management Effectiveness >> EXAI's 5 Years Annual ROE >> Compare EXAI ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
EXAI's' Return on Equity at Yahoo Finance
EXAI's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for EXAI's Competitors
Subscribers only: Roe for Exscientia Plc's Suppliers
Subscribers only: Return On Equity for EXAI's Customers




Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector ROE

Date modified: 2026-09-18T16:28:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.